Insulin aspart, recombinant Subcutaneous and Zantac Cool Mint
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Zantac Cool Mint and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: ranitidine
Brand name: Zantac
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Zantac Injection
- Insulin aspart, recombinant Subcutaneous-Zapzyt Cleansing Topical
- Insulin aspart, recombinant Subcutaneous-Zapzyt Topical
- Insulin aspart, recombinant Subcutaneous-Zarah
- Insulin aspart, recombinant Subcutaneous-Zarontin
- Insulin aspart, recombinant Subcutaneous-Zarontin (Ethosuximide Capsules)
- Zantac Cool Mint-Insulin degludec
- Zantac Cool Mint-Insulin Degludec (U-100) Prefilled Pens
- Zantac Cool Mint-Insulin Degludec (U-100) Vials
- Zantac Cool Mint-Insulin Degludec (U-200) Prefilled Pens
- Zantac Cool Mint-Insulin degludec and liraglutide
- Zantac Cool Mint-Insulin degludec and liraglutide Subcutaneous